國立虎尾科技大學 |

Behavioral Clinical Trials for Chronic Diseases = Scientific Foundations /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Behavioral Clinical Trials for Chronic Diseases/ by Lynda H. Powell, Kenneth E. Freedland, Peter G. Kaufmann.
Reminder of title:	Scientific Foundations /
Author:	Powell, Lynda H.
other author:	Freedland, Kenneth E.
Description:	XVIII, 314 p. 40 illus., 22 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Health psychology. -
Online resource:	https://doi.org/10.1007/978-3-030-39330-4
ISBN:	9783030393304

Behavioral Clinical Trials for Chronic Diseases = Scientific Foundations /
Powell, Lynda H.

Behavioral Clinical Trials for Chronic DiseasesScientific Foundations /[electronic resource] :by Lynda H. Powell, Kenneth E. Freedland, Peter G. Kaufmann. - 1st ed. 2021. - XVIII, 314 p. 40 illus., 22 illus. in color.online resource.

Introduction: the window of opportunity -- A selected history of randomized behavioral clinical trials: what we learned -- A clinically significant problem and a clincially significant benefit -- The process of developing a behavioral treatment for chronic disease -- The hypothesized pathway from behavioral treatment to chronic disease -- Equipoise, blinding, and investigator discipline -- Sensitivity to diversity -- Protection of randomization -- Choice of appropriate control group -- Readiness to conduct a behavioral randomized clinical trial -- Concluding remarks.

This is the first comprehensive guide to the design of behavioral randomized clinical trials (RCT) for chronic diseases. It includes the scientific foundations for behavioral trial methods, problems that have been encountered in past behavioral trials, advances in design that have evolved, and promising trends and opportunities for the future. The value of this book lies in its potential to foster an ability to “speak the language of medicine” through the conduct of high-quality behavioral clinical trials that match the rigor commonly seen in double-blind drug trials. It is relevant for testing any treatment aimed at improving a behavioral, social, psychosocial, environmental, or policy-level risk factor for a chronic disease including, for example, obesity, sedentary behavior, adherence to treatment, psychosocial stress, food deserts, and fragmented care. Outcomes of interest are those that are of clinical significance in the treatment of chronic diseases, including standard risk factors such as cholesterol, blood pressure, and glucose, and clinical outcomes such as hospitalizations, functional limitations, excess morbidity, quality of life, and mortality. This link between behavior and chronic disease requires innovative clinical trial methods not only from the behavioral sciences but also from medicine, epidemiology, and biostatistics. This integration does not exist in any current book, or in any training program, in either the behavioral sciences or medicine.

ISBN: 9783030393304

Standard No.: 10.1007/978-3-030-39330-4doiSubjects--Topical Terms:

1109770
Health psychology.

LC Class. No.: R726.7

Dewey Class. No.: 616.89

Behavioral Clinical Trials for Chronic Diseases = Scientific Foundations /
LDR:03458nam a22003855i 4500 001 1056240
003 DE-He213
005 20211013130535.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030393304 $9 978-3-030-39330-4
024 7 $a 10.1007/978-3-030-39330-4 $2 doi
035 $a 978-3-030-39330-4
050 4 $a R726.7
072 7 $a MBNH9 $2 bicssc
072 7 $a PSY003000 $2 bisacsh
072 7 $a MBNH9 $2 thema
082 0 4 $a 616.89 $2 23
100 1 $a Powell, Lynda H. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1361572
245 1 0 $a Behavioral Clinical Trials for Chronic Diseases $h [electronic resource] : $b Scientific Foundations / $c by Lynda H. Powell, Kenneth E. Freedland, Peter G. Kaufmann.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XVIII, 314 p. 40 illus., 22 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction: the window of opportunity -- A selected history of randomized behavioral clinical trials: what we learned -- A clinically significant problem and a clincially significant benefit -- The process of developing a behavioral treatment for chronic disease -- The hypothesized pathway from behavioral treatment to chronic disease -- Equipoise, blinding, and investigator discipline -- Sensitivity to diversity -- Protection of randomization -- Choice of appropriate control group -- Readiness to conduct a behavioral randomized clinical trial -- Concluding remarks.
520 $a This is the first comprehensive guide to the design of behavioral randomized clinical trials (RCT) for chronic diseases. It includes the scientific foundations for behavioral trial methods, problems that have been encountered in past behavioral trials, advances in design that have evolved, and promising trends and opportunities for the future. The value of this book lies in its potential to foster an ability to “speak the language of medicine” through the conduct of high-quality behavioral clinical trials that match the rigor commonly seen in double-blind drug trials. It is relevant for testing any treatment aimed at improving a behavioral, social, psychosocial, environmental, or policy-level risk factor for a chronic disease including, for example, obesity, sedentary behavior, adherence to treatment, psychosocial stress, food deserts, and fragmented care. Outcomes of interest are those that are of clinical significance in the treatment of chronic diseases, including standard risk factors such as cholesterol, blood pressure, and glucose, and clinical outcomes such as hospitalizations, functional limitations, excess morbidity, quality of life, and mortality. This link between behavior and chronic disease requires innovative clinical trial methods not only from the behavioral sciences but also from medicine, epidemiology, and biostatistics. This integration does not exist in any current book, or in any training program, in either the behavioral sciences or medicine.
650 0 $a Health psychology. $3 1109770
650 0 $a Health promotion. $3 565089
650 0 $a Complementary medicine. $3 1255001
650 0 $a Behavioral therapy. $3 1257972
650 1 4 $a Health Psychology. $3 668198
650 2 4 $a Health Promotion and Disease Prevention. $3 593964
650 2 4 $a Complementary & Alternative Medicine. $3 679169
650 2 4 $a Behavioral Therapy. $3 593954
700 1 $a Freedland, Kenneth E. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1361573
700 1 $a Kaufmann, Peter G. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1361574
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030393281
776 0 8 $i Printed edition: $z 9783030393298
856 4 0 $u https://doi.org/10.1007/978-3-030-39330-4
912 $a ZDB-2-BSP
912 $a ZDB-2-SXBP
950 $a Behavioral Science and Psychology (SpringerNature-41168)
950 $a Behavioral Science and Psychology (R0) (SpringerNature-43718)